+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma



Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma



International Journal of Clinical and Experimental Pathology 8(1): 423-431



SATB2, a member of the family of special AT-rich binding proteins, has been shown to affect numerous tumorigenesis. However, the role of SATB2 in esophageal squamous cell carcinoma (ESCC) remains unclear. In this study, the SATB2 expression was examined at mRNA and protein levels by quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR), Western blotting, and immunohistochemistry in ESCC tissues and adjacent non-cancerous tissues. Statistical analyses were applied to test the associations between SATB2 expression, clinicopathologic factors, and prognosis. Western blotting and qRT-PCR showed that the expression levels of SATB2 mRNA and protein were both significantly lower in SATB2 tissues than those in non-cancerous tissues. Immunohistochemistry analysis showed that SATB2 expression was significantly correlated with clinical stage and Histological differentiation. The results of Kaplan-Meier analysis indicated that a low expression level of SATB2 resulted in a significantly poor prognosis of ESCC patients. Importantly, multivariate analysis showed that low SATB2 expression was an independent prognostic factor for ESCC patients. In sum, our data suggest that SATB2 plays an important role in ESCC progression, and that decreased expression of SATB2 in tumor tissues could be used as a potential prognostic marker for patients with ESCC.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058637571

Download citation: RISBibTeXText

PMID: 25755730


Related references

Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma. Anticancer Research 33(10): 4329-4335, 2013

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Annals of Thoracic Surgery 93(5): 1682-1688, 2012

Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Annals of Surgical Oncology 14(9): 2621-2627, 2007

Prognostic significance of ICAM-1 expression in patients with esophageal squamous cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 42: 798, 2001

Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Oncology Reports 15(2): 323-328, 2006

Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients. Nan Fang Yi Ke Da Xue Xue Bao 33(1): 99-102, 2014

Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 94(7): 1955-1960, April 1, 2002

CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 23(3): 936-942, 2016

Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients. Journal of Surgical Oncology 105(2): 183-188, 2012

Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis. Journal of Thoracic Disease 8(11): 3197-3204, 2017

Clinical and prognostic significance of MUC1 expression in patients with esophageal squamous cell carcinoma after radical resection. Saudi Journal of Gastroenterology 24(3): 165-170, 2018

Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncology Reports 18(4): 981-985, 2007

Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis. Plos One 7(9): E44764, 2013

Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncology Reports 15(6): 1551-1555, 2006

Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma. Anticancer Research 33(6): 2699-2705, 2013